Renaissance Technologies’s Quoin Pharmaceuticals QNRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-3,803
| Closed | -$86.6K | – | 3766 |
|
2024
Q4 | $86.6K | Buy |
3,803
+2,698
| +244% | +$61.5K | ﹤0.01% | 3306 |
|
2024
Q3 | $19.1K | Buy |
1,105
+128
| +13% | +$2.21K | ﹤0.01% | 3429 |
|
2024
Q2 | $19.8K | Sell |
977
-352
| -26% | -$7.15K | ﹤0.01% | 3384 |
|
2024
Q1 | $44K | Buy |
+1,329
| New | +$44K | ﹤0.01% | 3503 |
|
2023
Q2 | – | Sell |
-33
| Closed | -$7K | – | 4207 |
|
2023
Q1 | $7K | Buy |
+33
| New | +$7K | ﹤0.01% | 3902 |
|
2022
Q3 | – | Sell |
-12
| Closed | -$29K | – | 4343 |
|
2022
Q2 | $29K | Buy |
12
+2
| +20% | +$4.83K | ﹤0.01% | 4082 |
|
2022
Q1 | $67K | Sell |
10
-6
| -38% | -$40.2K | ﹤0.01% | 3856 |
|
2021
Q4 | $152K | Buy |
16
+9
| +129% | +$85.5K | ﹤0.01% | 3602 |
|
2021
Q3 | $670K | Buy |
7
+1
| +17% | +$95.7K | ﹤0.01% | 2759 |
|
2021
Q2 | $433K | Hold |
6
| – | – | ﹤0.01% | 3016 |
|
2021
Q1 | $418K | Sell |
6
-1
| -14% | -$69.7K | ﹤0.01% | 2979 |
|
2020
Q4 | $320K | Sell |
7
-4
| -36% | -$183K | ﹤0.01% | 3010 |
|
2020
Q3 | $466K | Sell |
11
-2
| -15% | -$84.7K | ﹤0.01% | 2833 |
|
2020
Q2 | $868K | Buy |
13
+4
| +44% | +$267K | ﹤0.01% | 2611 |
|
2020
Q1 | $275K | Buy |
9
+4
| +80% | +$122K | ﹤0.01% | 3009 |
|
2019
Q4 | $227K | Buy |
5
+1
| +25% | +$45.4K | ﹤0.01% | 3162 |
|
2019
Q3 | $183K | Buy |
4
+1
| +33% | +$45.8K | ﹤0.01% | 3170 |
|
2019
Q2 | $171K | Buy |
3
+2
| +200% | +$114K | ﹤0.01% | 3330 |
|
2019
Q1 | $148K | Buy |
+1
| New | +$148K | ﹤0.01% | 3252 |
|